What is LOPJLB’s current signal on DTIL?

LOPJLB’s latest quantitative signal on Precision BioSciences, Inc. (DTIL) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is DTIL in?

Precision BioSciences, Inc. (DTIL) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Where is Precision BioSciences, Inc. based / listed?

Precision BioSciences, Inc. is based in US, listed on NASDAQ.

Precision BioSciences, Inc. (DTIL)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$6.43+2.88%Close

SELLRECOVERY · day 1

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $82M
Beta: 1.27
P/E (TTM): -2.22

Short % float: 22.58%
Days to cover: 10.6
SI change: -11.7%

1W: +1.58%
1M: -11.31%

vs SPY 1W: +0.02%
vs SPY 1M: -13.07%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Precision BioSciences, Inc. is a clinical-stage biotechnology firm based in the United States, specializing in the creation of both in vivo gene editing solutions and ex vivo allogeneic CAR T-cell therapies. At its core is ARCUS, a proprietary genome editing platform designed…

Employees: 67
Headquarters: US
Founded: 2019
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 12.8M
Float: 76.8%

precisionbiosciences.com ↗

Key executives

Michael Amoroso — President, Chief Executive Officer & Director

Naresh Tanna — Chief of Staff to Chief Executive Officer & Head of Investor Relations

John Alexander Kelly — Chief Financial Officer & Principal Accounting Officer

SEC filings

EDGAR · CIK 13578740 · DTIL

Analyst consensus

Buy

Bullish975.0%

Neutral325.0%

Bearish00.0%

L $20.00Avg $20.00H $20.00

Target$20.00+211.04%

Last$6.43

Key stats

Prediction markets

Company news